Mustafa Orhan
Research Subjects
Research Interests
Mustafa Orhan has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Ayca Tas Tuna
Department of Anaesthesiology and Reanimation, Sakarya University Faculty of Medicine, Sakarya, Turkey
1 shared publication - Fatih Şahin
Faculty of Medicine, Anesthesiology and Reanimation, Sakarya University, Sakarya, Turkey
1 shared publication - Hüseyin Çakıroğlu
Experimental Animal Unit, Faculty of Medicine, Sakarya University, Adapazarı, Türkiye, Turkey (Türkiye)
1 shared publication - Nevcihan Şahutoğlu Bal
Department of Pain Medicine, Ankara Bilkent City Hospital, Ankara 06800, Türkiye
1 shared publication - Onur Palabiyik
Sakarya Univ, Fac Med, Anesthesiol & Reanimat Dept, Sakarya, Turkiye
1 shared publication - Sezen Irmak Gözükara
Sakarya Training and Research Hospital Clinic of Medical Biochemistry Adapazarı Sakarya Turkey Clinic of Medical Biochemistry, Sakarya Training and Research Hospital, Adapazarı, Sakarya, Turkey
1 shared publication
Latest Publications
- 20 October 2022
- Published by Konuralp Medical Journal in Konuralp Tip Dergisi
- Vol. 14 (3) , 520-525
Sıçanlarda Hepatik İskemi Reperfüzyon Hasarında Farklı Dozlarda Amantadin'in Akciğer Dokusu Üzerine Etkisi
Objective: N-Methyl D-Aspartate (NMDA) receptor blockers have been shown to have protective effects against ischemia/reperfusion (I/R) injury in various tissues. The aim of this study was to investigate the effects of 90 ve 135 mg/kg doses of amantadine on lung in hepatic I/R injury. Method: The rats were randomly divided into six groups: Group Sham, Group I/R, Group Amantadine-90, Group Amantadine-135, Group I/R-90 and Group I/R-135. In I/R, an atraumatic vascular clamp was applied to the structures in the left portal triad for 45 minutes and reperfusion period was 2 hours after ischemia. Malondialdehyde (MDA), superoxide dismutase (SOD) and catalase (CAT) enzyme levels were performed the lung tissue and tissues were examined histopathologically. Result: A significant difference was found between the groups in terms of MDA, SOD, CAT levels (respectively; p < 0.001, p=0.008, p < 0.001). A significant difference was found between the groups in terms of lung tissue neutrophil/lymphocyte infiltration scores and alveolar wall thickening scores (respectively p=0.009, p=0.002). Conclusion: The biochemical and histopathological results of the present study suggested that amantadine, like other NMDA antagonist agents, may have a protective effect on lung tissues against the damage caused by hepatic I/R injury. Although we observed significant improvements after the administration of both doses studied, there was no significant difference between these two doses in terms of their success in protecting against distant organ lung injury. Amantadine appears promising as a therapeutic agent in treatment.
- 20 October 2022
- Published by Konuralp Medical Journal in Konuralp Tip Dergisi
- Vol. 14 (3) , 520-525
Sıçanlarda Hepatik İskemi Reperfüzyon Hasarında Farklı Dozlarda Amantadin'in Akciğer Dokusu Üzerine Etkisi
Objective: N-Methyl D-Aspartate (NMDA) receptor blockers have been shown to have protective effects against ischemia/reperfusion (I/R) injury in various tissues. The aim of this study was to investigate the effects of 90 ve 135 mg/kg doses of amantadine on lung in hepatic I/R injury. Method: The rats were randomly divided into six groups: Group Sham, Group I/R, Group Amantadine-90, Group Amantadine-135, Group I/R-90 and Group I/R-135. In I/R, an atraumatic vascular clamp was applied to the structures in the left portal triad for 45 minutes and reperfusion period was 2 hours after ischemia. Malondialdehyde (MDA), superoxide dismutase (SOD) and catalase (CAT) enzyme levels were performed the lung tissue and tissues were examined histopathologically. Result: A significant difference was found between the groups in terms of MDA, SOD, CAT levels (respectively; p < 0.001, p=0.008, p < 0.001). A significant difference was found between the groups in terms of lung tissue neutrophil/lymphocyte infiltration scores and alveolar wall thickening scores (respectively p=0.009, p=0.002). Conclusion: The biochemical and histopathological results of the present study suggested that amantadine, like other NMDA antagonist agents, may have a protective effect on lung tissues against the damage caused by hepatic I/R injury. Although we observed significant improvements after the administration of both doses studied, there was no significant difference between these two doses in terms of their success in protecting against distant organ lung injury. Amantadine appears promising as a therapeutic agent in treatment.